Compare CDMOs specializing in small molecule API synthesis from route scouting through commercial manufacturing. Filter by chemistry capabilities, scale, and regulatory approvals.
518 companies listed
Canada
SEQENS is a global integrated CDMO and specialty ingredients leader with 15 production sites across 9 countries and 5 R&D centers. The company manufactures custom and generic APIs, intermediates, excipients, custom lipids for drug delivery (mRNA/siRNA, LNP), HPAPIs, and specialty chemicals. SEQENS also operates CELLforCURE, an EMA-authorized CDMO for Advanced Therapy Medicinal Products (ATMPs/Cell & Gene Therapy). The company serves 1,500+ customers in 80+ countries with approximately 2,700 employees and ~1B EUR revenue.
Germany
SERATEC is a French-German CDMO specializing in the development and production of active pharmaceutical ingredients (APIs) for rare and orphan diseases as well as high-value small molecules. Founded in 1970, the company provides end-to-end API solutions from molecule design through development, registration with leading regulatory agencies, and cGMP commercial production. SERATEC is FDA-registered and has been FDA-inspected for API manufacturing.
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.